BEGUM BATES: Open Payments
NPI 1659972677 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,673 in 38 payments from 22 companies in 2025. Trend: 2023 $1,383 · 2024 $2,136 · 2025 $3,673
Food & beverage: $3,561Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $489 |
| Teva Pharmaceuticals USA, Inc. | 5 | $481 |
| Axsome Therapeutics, Inc. | 4 | $401 |
| Alexion Pharmaceuticals, Inc. | 4 | $337 |
| Aimmune Therapeutics, Inc. | 2 | $171 |
| Bioventus LLC | 2 | $155 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| ARGENX US, INC. | 1 | $125 |
| BridgeBio Pharma, Inc. | 1 | $124 |
| Madrigal Pharmaceuticals | 1 | $124 |
Products named: AUSTEDO XR, VRAYLAR, Auvelity, ZENPEP, ULTOMIRIS, INGREZZA, VYVGART, Attruby.
Industry payments across OH — which companies pay providers there.
